CTC
EVH icon

Central Trust Company’s Evolent Health EVH Stock Holding History

Central Trust Company’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-700
Closed -$19.8K – 1449
2024
Q3 		$19.8K Hold
700
– – ﹤0.01% 955
2024
Q2 		$13.4K Sell
700
-35
-5% -$894 ﹤0.01% 1012
2024
Q1 		$24.1K Hold
735
– – ﹤0.01% 933
2023
Q4 		$24.3K Hold
735
– – ﹤0.01% 923
2023
Q3 		$20K Hold
735
– – ﹤0.01% 934
2023
Q2 		$22.3K Hold
735
– – ﹤0.01% 917
2023
Q1 		$23.9K Hold
735
– – ﹤0.01% 913
2022
Q4 		$20.6K Hold
735
– – ﹤0.01% 905
2022
Q3 		$26K Hold
735
– – ﹤0.01% 891
2022
Q2 		$23K Hold
735
– – ﹤0.01% 903
2022
Q1 		$24K Buy
735
+35
+5% +$916 ﹤0.01% 927
2021
Q4 		$19K Hold
700
– – ﹤0.01% 954
2021
Q3 		$22K Hold
700
– – ﹤0.01% 902
2021
Q2 		$15K Buy
+700
New +$14K ﹤0.01% 942

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Central Trust Company's EVH Position: Q4 2024 in Review

Central Trust Company sold out of Evolent Health (EVH) in Q4 2024, closing a stake of 700 shares — an estimated $19.8K sold.

Central Trust Company first reported a position in EVH in Q2 2021 and held it in 14 quarters. The position peaked at $26K in Q3 2022. 240 funds tracked by Wall St. Rank hold EVH as of Q4 2024.

  • Central Trust Company reported no remaining Evolent Health position as of Q4 2024 after selling out during the quarter.
  • Central Trust Company sold 700 Evolent Health shares in Q4 2024, an estimated $19.8K.
  • Central Trust Company first reported a position in Evolent Health in Q2 2021 and held it in 14 quarters.
  • Central Trust Company's Evolent Health position peaked at $26K in Q3 2022.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q4 2024.

Based on Central Trust Company's 13F filing for Q4 2024, filed 24 Jan 2025.